Search research articles
Contact Us
Filters
Showing results (111-120 of 146) with videos related to
Page
of 15
Sort By:
Annals of Internal Medicine
|
November 6, 2002
Successful discontinuation of therapy for disseminated Mycobacterium avium complex infection after effective antiretroviral therapy
Stephen D Shafran, Laura D Mashinter, Peter Phillips, et al.
Journal of Addictive Diseases
|
August 3, 2022
Health-related quality of life in people receiving opioid agonist treatment and treatment for hepatitis C virus infection
Olav Dalgard, Alain H Litwin, Oren Shibolet, et al.
Journal of Virology
|
February 14, 2004
Genetic basis of hypersusceptibility to protease inhibitors and low replicative capacity of human immunodeficiency virus type 1 strains in primary infection
Andrew J Leigh Brown, Simon D W Frost, Benjamin Good, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
May 19, 2017
Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse
François M J Lamoury, Angelica Soker, Danica Martinez, et al.
The International Journal on Drug Policy
|
June 22, 2017
Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study
Håvard Midgard, Behzad Hajarizadeh, Evan B Cunningham, et al.
Patient Preference and Adherence
|
December 20, 2022
Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286)
Marina B Klein, Jim Young, David Ortiz-Paredes, et al.
Plos One
|
January 28, 2014
Micronutrient deficiency and treatment adherence in a randomized controlled trial of micronutrient supplementation in ART-naïve persons with HIV
Louise Balfour, Johanna N Spaans, Dean Fergusson, et al.
The Journal of Infectious Diseases
|
January 20, 2011
Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infection
Amie L Meditz, Samantha MaWhinney, Amanda Allshouse, et al.
HIV Clinical Trials
|
October 25, 2007
Randomized controlled trial of once-daily tenofovir, lamivudine, and lopinavir/ritonavir versus remaining on the same regimen in virologically suppressed HIV-infected patients on their first PI-containing HAART regimen
Mona R Loutfy, Nabil Ackad, Tony Antoniou, et al.
Canadian Liver Journal
|
August 22, 2022
The Z-Profile Study: a multicenter, retrospective cohort study to assess the real-world use and effectiveness of elbasvir/grazoprevir in Canadian adult patients with chronic hepatitis C
Edward Tam, Julie Tremblay, Chris Fraser, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 146) with videos related to
Sort By:
Page
of 15
Annals of Internal Medicine
|
November 6, 2002
Successful discontinuation of therapy for disseminated Mycobacterium avium complex infection after effective antiretroviral therapy
Stephen D Shafran, Laura D Mashinter, Peter Phillips, et al.
Journal of Addictive Diseases
|
August 3, 2022
Health-related quality of life in people receiving opioid agonist treatment and treatment for hepatitis C virus infection
Olav Dalgard, Alain H Litwin, Oren Shibolet, et al.
Journal of Virology
|
February 14, 2004
Genetic basis of hypersusceptibility to protease inhibitors and low replicative capacity of human immunodeficiency virus type 1 strains in primary infection
Andrew J Leigh Brown, Simon D W Frost, Benjamin Good, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
May 19, 2017
Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse
François M J Lamoury, Angelica Soker, Danica Martinez, et al.
The International Journal on Drug Policy
|
June 22, 2017
Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study
Håvard Midgard, Behzad Hajarizadeh, Evan B Cunningham, et al.
Patient Preference and Adherence
|
December 20, 2022
Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286)
Marina B Klein, Jim Young, David Ortiz-Paredes, et al.
Plos One
|
January 28, 2014
Micronutrient deficiency and treatment adherence in a randomized controlled trial of micronutrient supplementation in ART-naïve persons with HIV
Louise Balfour, Johanna N Spaans, Dean Fergusson, et al.
The Journal of Infectious Diseases
|
January 20, 2011
Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infection
Amie L Meditz, Samantha MaWhinney, Amanda Allshouse, et al.
HIV Clinical Trials
|
October 25, 2007
Randomized controlled trial of once-daily tenofovir, lamivudine, and lopinavir/ritonavir versus remaining on the same regimen in virologically suppressed HIV-infected patients on their first PI-containing HAART regimen
Mona R Loutfy, Nabil Ackad, Tony Antoniou, et al.
Canadian Liver Journal
|
August 22, 2022
The Z-Profile Study: a multicenter, retrospective cohort study to assess the real-world use and effectiveness of elbasvir/grazoprevir in Canadian adult patients with chronic hepatitis C
Edward Tam, Julie Tremblay, Chris Fraser, et al.
Page
of 15